|
2023
|
Invention
|
Therapeutic compounds and compositions for treating social disorders and substance use disorders.... |
|
2022
|
Invention
|
Non-peptide oxytocin receptor agonists.
Disclosed herein are compounds according to Formula I; a... |
|
|
Invention
|
Methods of treatment.
The present invention provides methods for treating or preventing aggressi... |
|
|
Invention
|
Methods of treatment. The present invention provides methods for treating or preventing aggressio... |
|
2021
|
Invention
|
Salts and crystals.
This invention relates to solid forms of 1-methyl-1,4,5, IO-tetrahydropyrazo... |
|
|
Invention
|
Salts and crystals. This invention relates to solid forms of 1-methyl-1,4,5,10-tetrahydropyrazolo... |
|
2020
|
Invention
|
Treatment of opioid withdrawal.
This invention relates to methods of treating, preventing, manag... |
|
|
Invention
|
Treatment of opioid withdrawal. This invention relates to methods of treating, preventing, managi... |
|
2019
|
Invention
|
Methods for management of weight.
Disclosed herein are methods for causing weight loss, for mana... |
|
|
Invention
|
Non-peptide oxytocin receptor agonists. Disclosed herein are compounds according to Formula I; a ... |
|
2018
|
Invention
|
Metabolite inspired selective oxytocin receptor agonists. The present disclosure relates to compo... |
